Evidence map›Paper›PMID 33597150›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2021

Functional Characteristics and Phenotypic Plasticity of CD57

Brian I Shaw, Jaclyn R Espinosa, Linda Stempora, Allison Miller, Bartley Adams, Allan D Kirk

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Immunotherapy for Cancer in Kidney Transplant Patients: A Difficult Balance Between Risks and Benefits.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Brian I ShawDepartment of Surgery, Duke University, Durham, NC 27710 brian.shaw@duke.edu.ORCID 0000-0002-2317-6549
Jaclyn R EspinosaDepartment of Surgery, Duke University, Durham, NC 27710.
Linda StemporaDepartment of Surgery, Duke University, Durham, NC 27710.
Allison MillerDepartment of Surgery, Duke University, Durham, NC 27710.
Bartley AdamsDepartment of Surgery, Duke University, Durham, NC 27710.
Allan D KirkDepartment of Surgery, Duke University, Durham, NC 27710.ORCID 0000-0003-2004-5962
Duke University · US

Funding

Phase 2 Study of Belatacept, Alemtuzumab, and Sirolimus in Renal TransplantationR01FD003539 · FDA · EMORY UNIVERSITY · PI KIRK, ALLAN D. · 2008 to 2019
$3.8M
Stimulating Access to Research in Residency (StARR) - NIAIDR38AI140297 · NIAID · DUKE UNIVERSITY · PI Rachel G Greenberg, David H. Harpole · 2018 to 2026
$2.4M
FDA HHS R01 FD003539NIAID NIH HHS R38 AI140297
6 · The paper itself

Abstract

Costimulation blockade (CoB)-based immunosuppression offers the promise of improved transplantation outcomes with reduced drug toxicity. However, it is hampered by early acute rejections, mediated at least in part by differentiated, CoB-resistant T cells, such as CD57

Indexed as

Kidney TransplantationAbataceptAdultCD4-Positive T-LymphocytesCD57 AntigensCell PlasticityCytomegalovirusCytomegalovirus InfectionsDrug SynergismFemaleGene Expression RegulationGraft RejectionHumansImmunosuppression TherapyImmunosuppressive AgentsKidney Failure, ChronicAbataceptCD57 AntigensImmunosuppressive AgentsPDCD1 protein, humanProgrammed Cell Death 1 ReceptorSirolimusTacrolimus

Identifiers

PMID33597150
PMCPMC7987798
OpenAlexW3130118164

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.